The purpose of the present study was to evaluate the effect of local application of Autologous Conditioned Plasma (ACP) on the treatment of full-thickness cartilage injuries of the knee. The hypothesis of the study was . that ACP can enhance healing response of injured cartilage. A full-thickness chondral lesion on the weight-bearing area of the medial femoral condyle was performed in 30 sheep. Animals were divided into 2 groups, according to postoperative treatment: in group 1, weekly injections of ACP for five times were performed; in group 2, lesions were left untreated. Animals were sacrificed at 3, 6 and 12 months after treatment. A histological evaluation was performed according to a modified O'Driscoll histological score. Comparison between groups for each time interval was performed with the Student's r-test, Significance was set at P <0.05. A post-hoc power analysis was performed according to the hypothesis of the study. Histological evaluation at 3 and 6 months showed that group 1 had significantly greater total score than group 2. At 12 months, no significant difference was observed between groups.
Focal articular cartilage injuries frequently results from traumas, or progressive osteoarthritic changes. Unfortunately, articular cartilage damage cannot be repaired and often it progresses until complete tissue wearing. Surgical treatment of these injuries aims at restoration of normal knee function by reconstruction of cartilage; however, none of the currently available treatments have been shown to regenerate hyaline cartilage [I~2] .
Growth factors (GFs) may have therapeutic effects on chondral injuries via multiple mechanisms including recruitment of chondrogenic cells (chemotaxis), stimulation of chondrogenic cell proliferation (mitogenesis), enhancement of cartilage matrix biosynthesis, and secretion of hyaluronic acid. Several in vitro and in vivo studies [3] [4] [5] [6] showed that TGF-/3s (/32, /33), BMP-2, 4, 6, and 7, FGF-18, and IGF-I promote chondrogenic differentiation of mesenchymal stem cells (MSCs). Furthermore, TGF-/3s (/31, /32), BMP-2 and 7, FGF-2, bFGF, PDGF, and IGF-I improve chondrocyte proliferation and metabolism [4, [7] [8] [9] .
One of the most relevant sources of the abovementioned GFs are platelets. Recent in-vitro studies showed that platelet-derived GFs stimulate chondrocyte proliferation and matrix biosynthesis, and enhance proliferation and chondrogenic differentiation of MSCs [10, 11] . Autologous conditioned plasma (ACP) is a blood-derived product containing a high concentration of platelets that can have a potential beneficial effect on chondral injuries by in situ releasing of platelet-derived GFs. The purpose of the present study was to evaluate the effect of local application of ACP for the treatment of fullthickness cartilage injuries of the knee. The hypothesis of the study was that ACP can enhance healing response of injured cartilage.
MATERIALSAND METHODS
For the present study, we used 30 sheep (sarda ewes at dryoft) that came from the same extensive farming system. Age ranged from 36 to 44 months and weight ranged from 32 kg to 46 kg. Exclusion criteria for enrolment were: skeletal immaturity and degenerative changes of the stifle joint. Skeletal maturity was confirmed by stifle radiographs to ensure the closure of the growth plates. Degenerative changes were assessed on radiographic exams, and intraoperative macroscopic appearance of cartilage. All the animals underwent a veterinary examination to evaluate general health status. Research protocol was approved by the local Ethic Committee for Animal Experimentation.
Surgical technique
Surgery was performed using sterile conditions and under general anaesthesia. On each animal, a medial parapatellar arthrotomy was carried out on the right stifle. A full-thickness articular cartilage lesion on the weight-bearing area of the medial femoral condyle was then performed using an 8-mm harvester instrument for osteochondral transplantation (OATS System; Arthrex, Naples, FL). Non-calcified cartilage was removed from the defect using a hand curette, taking care of retaining calcified cartilage in the base of the defect. Accurate haemostasis and surgical wound closure were then performed, respecting anatomical layers.
Post-operative regimen
After surgery, the animals have been left free in their fencings without any immobilization of the operated limb. Full weight-bearing was allowed as tolerated. No specific exercise regimen was adopted. General health and weight-bearing status were monitored during recovery by a veterinary.
Treatment protocol
Animals were assigned to two groups (fifteen animals for each group), according to postoperative treatment. In group I, five intraarticular injections of ACP into the operated knee were performed, according to the following scheme: first injection at 24 hours after surgery, then one injection every week for four times. In group 2, operated knees were left untreated.
ACP preparation
ACP was prepared using an apposite sterile double syringe (Arthrex BioSystems; Naples, FL). Ten millilitres of autologous venous blood were withdrawn into the outer syringe. Blood was centrifugated at 1300 rpm for 5 minutes. The supernatant was collected into the inner syringe and the final product, consisting of 2-3 ml of liquid ACP, was used for intraarticular injections.
Randomization
Fifteen animals were randomly assigned to each group. Randomization was performed using a random number generator. The randomization list was then kept by an independent researcher, and the assignment code of each animal was revealed to the investigators only at the end of surgery.
Endpoints
Animals were euthanized by intravenous injection of I ml/kg pentobarbital sodium 3, 6 and 12 months after treatment (five animals from each group at every time interval). At the time of sacrifice, the medial femoral condyles of the operated limbs were harvested after removing all peri-articular soft tissues.
Outcome measurement
Histological assessment was considered the primary outcome of the study. Samples were fixed in 10% buffered neutral formalin for 7 days, decalcified in ethylene diamine tetra-acetate (EDTA) buffered saline (pH 7.4) (0.25 mol/I), dehydrated by serial ethanol washing and embedded in paraffin wax. Five sagittal cuts (6 urn thick) from the central part of the defect were obtained, using a motorized microtome. Slices were stained with haematoxylin eosin (H&E) and Safranin-O/fast green, and examined under the light microscope. Each slice was evaluated by three different investigators well-experienced in histological assessment of musculoskeletal tissues and blind to treatment, and scored according to a modified O'Driscoll grading system [12] (Table I) .
Data analysis
Data were analyzed using statistical software (SPSS 19; SPSS Inc., Chicago, IL, USA). Outcome measurements were expressed as mean values + standard deviations (SD).
Comparison between groups at each time period (3, 6, and 12 months after treatment) was performed with the Student's t-test. 95% confidence intervals (95% CIs) of estimated differences between means were calculated for each comparison. Significance was set at P <0.05. A post-hoc power analysis was performed according to the objective ofthe study.
RESULTS
No intraoperative or postoperative complications were reported, nor adverse events related to treatment with ACP. Histological evaluation at 3 months showed no evident repair tissue in both groups (Fig 1) . Tidemark was preserved, according to surgical procedure. Some cell clusters were observed in the deepest zone of the defect in group 1. Healthy cartilage surrounding the defect showed signs of suffering with a poor Safranino staining, an intense cell proliferation and clusters of chondrocyte-like cells in the transitional and radial zones in both groups. At 6 months, we observed that in group I, a thin layer of fibrous tissue covered almost completely the defect, with a slight basal integration but poor integration with the surrounding healthy cartilage. Repair tissue was thinner in the inner part and thicker on the border of the defect, where it showed slight Safranin-O staining, and the presence of some rounded cells. Tidemark was almost completely preserved, but it did not appear completely intact. Surrounding cartilage flowed over the lesion, thus reducing the defect area. It showed an intense cell proliferation with formation of cell clusters and strong Safranin-O staining (Fig. 2) . In group 2, histological findings did not substantially differ from those observed in three months samples, except for a thin layer of tissue flowing over the borders of the defect from the surrounding cartilage, containing some cell clusters ( Fig. 3) . At 12 months, we observed that in group I, there was a slight deterioration of repair tissue covering the defect. Some cell clusters were present, but tissue was thinner than that observed in six- (Fig. 4) . Similarly, tidemark disruption was observed in samples of group 2, which showed no other relevant changes in comparison with those of previous time periods. Histological scoring assessment at 3 months (Table II) showed that group 1 had significantly greater scores than group 2 for the following variables: tissue morphology (Ti), chondrocyte clustering (Clus), and total score. At 6 months (Table III) , group I showed significantly greater scores than group 2 for tissue morphology (Ti), matrix staining (Matx), structural integrity (Stru), basal integration (Bas!), and total score. At 12 months (Table IV) , group I showed significantly greater scores than group 2 for matrix staining (Matx), and basal integration (Bas!).
Power analysis
Post-hoc power analysis based on the primary outcome (histological score) at first endpoint (3 months) showed an effect size of 1.92 and a power (I-~) of 0.88.
DISCUSSION
The results of the present study showed that conservative treatment of full-thickness chondral injuries of the knee by multiple injections of ACP was unable to restore hyaline cartilage. However, it promoted a strong reparative response from the healthy surrounding cartilage, which flowed over the borders of the defect, with reduction of the area of the defect, and formation of a thin layer of repair tissue over the defect showing some metabolic activity at Safranin-O staining, especially in the peripheral area of the defect. Moreover, repair tissue contained some cell clusters in the early phase, and rounded cells resembling chondrocytes at 6 months after treatment. Strongest reparative response was observed at 6 months. Thereafter, a deterioration of repair tissue was observed, histological findings at 12 months being similar to those observed at 3 months. Progressive disruption of the tidemark with involvement of the calcified cartilage was evident over time.
The results of the present study also confirmed that untreated full-thickness chondral defects do not evolve towards healing, and reparative response from surrounding cartilage remains confined within the borders of the lesion and does not involve the defect area. Untreated lesions did not show relevant differences over time, except for increasing tidemark disruption, which implies degenerative changes of the deepest zone of the lesion through the calcified cartilage, with progressive exposure of the subchondral bone, as observed in the natural history of osteoarthritis [13] . Nevertheless, progressive degenerative changes in both groups were rather mild and slow, as the design of the present study implied a full-thickness defect of articular cartilage, but did not reproduce an experimental model of osteoarthritis [14] and therefo -e, some risk factors of progression of chondral injury to osteoarthritis, such as limb malalignment, total meniscectomy and/or joint instability, were absent.
Blood derived growth factors have already been studied for their potential in helping cartilage repair and documented in the literature. In vitro studies showed that platelets concentrates have a positive effect on chondrocyte proliferation and differentiation [15] while in vivo studies demonstrated preventive effects against OA progression and articular cartilage healing acceleration [16] [17] [18] . Kon et al [19] reported a pilot study on 100 patients affected by chronic degenerative condition of the knee, and treated with platelet rich plasma (PRP) intra-articular injections. The results remained stable from the end of the therapy to 6 months follow up, whereas they became significantly worse at 12 months follow up, even if still significantly higher respect to the basal level. Milano et al [20] , in an experimental study on sheep model, showed that PRP had a positive effect on cartilage repair and restoration after microfracture and that the procedure was more effective when PRP was used as a gel in comparison with liquid intra-articular injection. However, differently from the present study, PRP was injected once at the end of surgical procedure, and was not repeated over time.
Several PRP preparation systems are now available that enable efficient preparation for outpatient use. Recently, Mazzucco et al [21] showed that there are noticeable differences in platelet concentration and GF release in similar methods for platelet gel preparation. For this reason, it impossible to generalize results on clinical efficacy of PRP, as studies reported in the literature differ for PRP preparation systems. Furthermore, debate continues regarding the optimal quantity of platelets and growth factors required for connective tissue healing [22] .
ACP showed some potential advantages in comparison with PRP. First, the amount of blood withdrawal (10 ml) is much less than that suggested for PRP preparation (about 50 ml); second, preparation of ACP requires a simpler procedure (only one blood centrifugation) than that suggested for PRP preparation (double centrifugation), with lesser risk ofblood contamination. On the other hand, despite difference in platelet concentration between ACP and some PRP preparations, growth factor concentration in ACP is similar to that reported in other PRP preparations [23] . Although ACP was unable to produce hyaline cartilage, it promoted a strong reparative response from healthy surrounding cartilage with a marked reduction of the area of the defect. This might have a crucial clinical relevance. In fact, if repeated over time, local application of ACP may maintain a reparative response. Moreover, a periodical release of GFs could prevent further degenerative changes and progression to OA both in the repair tissue and the surrounding cartilage.
Nevertheless, this study has some limits. First, inference of results cannot be extended to the treatment of OA, as we tested the effect of ACP on healthy knees with focal chondral defects. Second, although preliminary study to optimize centrifugation setting provided platelet concentration approximating twofold that of entire blood, we did not analyze growth factor content of ACP in animal blood. This is a relevant issue, as it is still unclear whether GF concentration is correlated with the amount of platelets. Finally, we did not compare ACP with other platelet concentrate preparations to find out whether eventual therapeutic effect on cartilage injuries varies according to differences in platelet concentration.
In conclusion, local injections ofACP for treatment of full-thickness cartilage injuries did not produce hyaline cartilage. However, it promoted reparative response with reduction of the area of the defect until 6 months after treatment.
